Literature DB >> 19877013

Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation.

Susanne A Keller1, Katrin Schwarz, Vania Manolova, Caroline E von Allmen, Matthias G Kinzler, Monika Bauer, Simone Muntwiler, Philippe Saudan, Martin F Bachmann.   

Abstract

Innate stimuli, such as TLR ligands, are known to greatly facilitate cross-priming. Currently it is unclear whether innate stimuli enhance cross-priming at the level of cross-presentation or at the level of T-cell priming. In this study, we addressed this question by measuring cross-presentation as well as cross-priming by virus-like particles (VLP) displaying peptide p33 derived of lymphocytic choriomeningitis virus. Innate stimuli were varied by either packaging different TLR ligands into virus-like particles or using mice deficient in two key molecules of TLR-signaling, namely the adaptor molecule MyD88 as well as IFN-alpha/beta receptor. While efficient cross-presentation occurred despite strongly reduced activation of DC in the absence of TLR ligand-mediated signals, T-cell priming was abolished. Thus, innate stimuli regulate cross-priming at the level of DC licensing for T-cell activation and not antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19877013     DOI: 10.1002/eji.200939559

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.

Authors:  François Dalençon
Journal:  Hum Vaccin Immunother       Date:  2013-08-12       Impact factor: 3.452

Review 2.  Designing CD8+ T cell vaccines: it's not rocket science (yet).

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Immunol       Date:  2010-05-04       Impact factor: 7.486

3.  Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.

Authors:  Anne-Cathrine S Vogt; Lukas Jörg; Byron Martina; Pascal S Krenger; Xinyue Chang; Andris Zeltins; Monique Vogel; Mona O Mohsen; Martin F Bachmann
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

4.  A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants.

Authors:  Paula M Berguer; Vanina A Alzogaray; Andrés Hugo Rossi; Juliana Mundiñano; Isabel Piazzon; Fernando A Goldbaum
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV.

Authors:  Muriel Sudres; Séverine Ciré; Virginie Vasseur; Léa Brault; Sylvie Da Rocha; Florence Boisgérault; Christine Le Bec; David Alexandre Gross; Véronique Blouin; Bernard Ryffel; Anne Galy
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

6.  Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice.

Authors:  Hongli Zhou; Li Guo; Min Wang; Jianguo Qu; Zhendong Zhao; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-01-05       Impact factor: 4.099

7.  Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.

Authors:  S J Win; D G G McMillan; F Errington-Mais; V K Ward; S L Young; M A Baird; A A Melcher
Journal:  Br J Cancer       Date:  2011-12-01       Impact factor: 7.640

8.  Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.

Authors:  Masahiko Arikata; Yasushi Itoh; Masatoshi Okamatsu; Toshinaga Maeda; Takashi Shiina; Keiko Tanaka; Shingo Suzuki; Misako Nakayama; Yoshihiro Sakoda; Hirohito Ishigaki; Ayato Takada; Hideaki Ishida; Kosuke Soda; Van Loi Pham; Hideaki Tsuchiya; Shinichiro Nakamura; Ryuzo Torii; Takeshi Shimizu; Hidetoshi Inoko; Iwao Ohkubo; Hiroshi Kida; Kazumasa Ogasawara
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.

Authors:  David A G Skibinski; Brendon J Hanson; Yufang Lin; Veronika von Messling; Andrea Jegerlehner; Jason Boon Sern Tee; De Hoe Chye; Steven K K Wong; Amanda A P Ng; Hui Yin Lee; Bijin Au; Bernett T K Lee; Lucia Santoso; Michael Poidinger; Anna-Marie Fairhurst; Alex Matter; Martin F Bachmann; Philippe Saudan; John E Connolly
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  Chemokines: a new dendritic cell signal for T cell activation.

Authors:  Christoph A Thaiss; Verena Semmling; Lars Franken; Hermann Wagner; Christian Kurts
Journal:  Front Immunol       Date:  2011-08-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.